Miscellaneous Uterine Malignant Neoplasms Detected during Hysteroscopic Surgery

Journal of Minimally Invasive Gynecology

Volumn 16, Issue 3, 2009, Pages 318-325

  Vilos, George A ^a   Edris, Fawaz ^a,b   Abu Rafea, Basim ^a,c   Hollett Caines, Jackie ^a   Ettler, Helen C ^a   Al Mubarak, Awatif ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Atypical leiomyoma (smooth muscle tumor of uncertain malignant potential); Atypical polypoid adenomyoma; Carcinosarcoma; Endometrial stromal sarcoma; Minimal deviation adenocarcinoma; Resectoscopic surgery

Indexed keywords

PROGESTERONE;

ABNORMAL UTERINE BLEEDING; ACCIDENTAL DEATH; ADENOMYOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CARCINOMATOSIS; CARCINOSARCOMA; CLINICAL ARTICLE; ELECTROCOAGULATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM ABLATION; ENDOMETRIUM SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; INCIDENTAL FINDING; LEIOMYOMA; MALIGNANT NEOPLASTIC DISEASE; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PATIENT COUNSELING; UTERINE CERVIX CARCINOMA; UTERUS BLEEDING; UTERUS CANCER;

ADULT; AGED, 80 AND OVER; ELECTROCOAGULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTEROSCOPY; INCIDENCE; INCIDENTAL FINDINGS; METRORRHAGIA; MIDDLE AGED; NEOPLASMS, COMPLEX AND MIXED; ONTARIO; SMOOTH MUSCLE TUMOR; SURVIVAL ANALYSIS; UTERINE NEOPLASMS;

EID: 65449176001     PISSN: 15534650     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmig.2009.02.004     Document Type: Article

References (65)

1. Lumsden MA; for the Guideline Development Group on Heavy Menstrual Bleeding. National Collaboration Centre for Women's and Children's Health NICE CG44, January 2007. Available at: team@ncc-wch.org.uk.
2. Shapley M., Jordan K., and Croft P.R. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract. 54 (2004) 359-363
3. Rose P.G. Endometrial carcinoma. N Engl J Med 335 (1996) 640-649
4. Farquhar C.M., Lethaby A., Sowter M., Verry J., and Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol 181 (1999) 525-529
5. Orr J.J., Chamberlain D., Kilgone L., and Naumann W. Management of endometrial cancer. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin No. 65. Obstet Gynecol. 106 (2005) 413-425
6. Spencer C.P., and Whitehead M.I. Endometrial assessment re-visited. [review]. Br J Obstet Gynaecol 106 (1999) 623-632
7. Takamizawa S., Mirakami H., Usui R., et al. Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecol Obstet Invest 48 (1998) 193-196
8. Kafy S., Huang J.Y.J., Al-Sunaidi M., et al. Audit of morbidity and mortality of 1792 hysterectomies. J Minim Invasive Gynecol 13 (2006) 55-59
9. Vilos G.A. Hysteroscopic and nonhysteroscopic endometrial ablation. Obstet Gynecol Clin North Am. 31 (2004) 687-704
10. Vilos G.A., Lefebvre G., and Graves G.R. Guidlines for the management of abnormal uterine bleeding: Society of Obstetrics and Gynaecology of Canada (SOGC) clinical practice guidlines. J Obstet Gynaecol Can 23 (2001) 704-709
11. Soysal M.E., Soysal S.K., and Vicdan K. Thermal balloon ablation in myoma induced menorrhagia under local anethesia. Gynecol Obstet Invest 51 (2001) 128-133
12. Glasser M.H., and Zimmerman J.D. The HydroThermAblator system for management of menorrhagia in women with submucous myomas: 12- to-20-month follow-up. J Am Assoc Gynecol Laparosc 10 (2003) 521-527
13. Mba E. The HTA systems for management of menorrhagia in women with myomas: 6- to-12-months follow-up. J Minim Invasive Gynecol 12 (2005) S60
14. Duleba A.J., and Dorey J. Treatment of submucous myomas by intrauterine cryoablation. J Am Assoc Gynecol Laparosc 11 (2004) S17
15. Kanaoka Y., Hiria K., and Ishiko O. Microwave endometrial ablation for menorrhagia caused by large submucous myomas. J Obstet Gynecol Res. 31 (2005) 565-570
16. Sabbah R., and Desaulniers G. Use of the NovaSure system in patients with submucous fibroids. J Minim Invasive Gynecol 12 (2005) S76
17. Vilos G.A., Harding P.G., Sugimoto A.K., Ettler H.C., and Bernier M.J. Hysteroscopic endomyometrial resection of three uterine sarcomas. J Am Assoc Gynecol Laparosc 8 (2001) 545-551
18. Vilos G.A., and Ettler H.C. Atypical polypoid adenomyoma and hysteroscopic endometrial ablation. J Obstet Gynaecol Can 25 (2003) 760-762
19. Vilos G.A., Ettler H.C., and Carey M. Minimal-deviation adenocarcinoma of the cervix encountered during hysteroscopic endometrial ablation. J Am Assoc Gynecol Laparosc 10 (2003) 119-122
20. Vilos G.A., Harding P.G., Silcox J.A., Sugimoto A.K., Carey M., and Ettler H.C. Endometrial adenocarcinoma encountered at the time of hysteroscopic endometrial ablation. J Am Assoc Gynecol Laparosc 9 (2002) 40-48
21. Vilos G.A., Edris F., Al-Mubarak A., Ettler H.C., Hollett-Caines J., and Abu-Rafea B. Hysteroscopic surgery does not adversely affect the long-term prognosis of women with endometrial adenocarcinoma. J Minim Invasive Gynecol 14 (2007) 205-210
22. Critchley H.O., Warner P., Lee A.J., Brechin S., Guise J., and Graham B. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess 8 (2004) 1-139 iii-iv
23. Clark T.J., Mann C.H., Shah N., Khan K.S., Song F., and Gupta J.K. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. Br J Obstet Gyencol 109 (2002) 313-321
24. Goldrath M.H., and Sherman A.I. Office hysteroscopy and suction curettage: can we eliminate the hospital diagnostic dilatation and curettage?. Am J Obstet Gynecol 152 (1985) 220-229
25. Gimpelson R.J., and Rappold H.O. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage: a review of 276 cases. Am J Obstet Gynecol 158 (1988) 489-492
26. Van Dongen J., de Kroon C.D., Jacobi C., et al. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. Br J Obstet Gynecol 114 (2007) 664-675
27. Vilos G.A., and Ettler H.C. Atypical complex endometrial hyperplasia treated with the GyneLase System. J Am Assoc Gynecol Laparosc 9 (2002) 73-78
28. Sharp N., Ellard M., Hirschowitz L., and Malthouse S. Johnson N. Successful microwave ablation of endometrial carcinoma. Br J Obstet Gynecol 109 (2002) 1410-1412
29. Kanaoka Y., Hiraik, and Ishiko O. Microwave endometrial ablation for complex endometrial hyperplasia with atypia. Int J Gynecol Obstet 85 (2004) 181-182
30. Dreisler E., and Sorensen S.S. Endometrial polyps: an epidemiological study of prevalence. J Am Assoc Gynecol Laparosc 11 (2004) S56
31. DeWaay D.J., Syrop C.H., Nygaard I.E., et al. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 100 (2002) 3-7
32. Lasmar R.B., Dias R., Barrozo P.R.M., et al. Prevalence of hysteroscopic findings and histologic diagnosis in patients with abnormal uterine bleeding. Fertil Steril 83 (2008) 1803-1807
33. Ortiz D.A., Ruiz-Garma A.G., Guisasola I.V., Famo F.M., Sigler V., and Martinez A.E. Outcomes of endometrial-polyp treatment with hysteroscopy in operating room. Gynecol Surg 5 (2008) 35-39
34. Ben-Arie A., Goldschmit C., Laviv Y., et al. The malignant potential of endometrial polyps. Eur J Obstet Gynecol Reprod Biol 115 (2004) 206-210
35. Lieng M., Ovigstad E., Sandvik L., Jorgensen H., Langebrekke A., and Istre O. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps. J Minim Invasive Gynecol 14 (2007) 189-194
36. Shushan A., Revel A., and Rojansky N. How often are endometrial polyps malignant?. Gynecol Obstet Invest 58 (2004) 212-215
37. Goldstein S.R., Monteagudo A., Popiolek D., et al. Evaluation of endometrial polyps. Am J Obstet Gynecol 186 (2002) 669-674
38. Garuti G., Sambruni I., Colonnelli M., et al. Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women. J Am Assoc Gynecol Laparosc 8 (2001) 207-213
39. Parker W.H., Fu Y.S., and Berek J.S. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83 (1994) 414-418
40. Leibsohn S., d'Ablaing G., Mishell Jr. D.R., and Schlaerth J.B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162 (1990) 968-976
41. Brand A., Dubuc-Lissoir J., Ehlen T.G., and Plante M. Diagnosis of endometrial cancer in women with abnormal vaginal bleeding: SOGC clinical practice guidlines. J Soc Obstet Gynaecol Can 22 (2000) 102-104
42. Romano S., Shimoni Y., Muralee D., and Shalev E. Retrograde seeding of endometrial carcinoma during hysteroscopy. Gynecol Oncol 44 (1992) 116-118
43. Schmitz M.J., and Nahhas W.A. Hysteroscopy may transport malignant cells into the peritoneal cavity: case report. Eur J Gynaecol Oncol 15 (1994) 121-124
44. Egarter C., Krestan C., and Kurz C. Abdominal dissemination of malignant cells with hysteroscopy. Gynecol Oncol 63 (1996) 143-144
45. Zerbe M.J., Zhang J., Bristow R.E., Grumbine F.C., Abularach S., and Montz F.J. Retrograde seeding of malignant cells during hysteroscopy in presumed early endometrial cancer. Gynecol Oncol 79 (2000) 55-58
46. Obermair A., Geramou M., Gucer F., et al. Does hysteroscopy facilitate tumor cell dissemination? incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D&C) versus hysteroscopy and D&C. Cancer 88 (2000) 139-143
47. Revel A., Tsafrir A., Anteby S., and Shusham A. Does hysteroscopy produce intraperitoneal spread of endometrial cancer cells?. Obstet Gynecol Surv 59 (2004) 280-284
48. Wilson A., and Duncan A. Peritoneal seeding after hysteroscopic diagnosis of cervical adenocarcinoma. Gynaecol Endosc 8 (1999) 179-181
49. Benifla J.L., Filippini F., Darai E., et al. Operative hysteroscopy procedure on an unsuspected mixed mullerian tumor of the uterus. Gynaecol Endosc 6 (1997) 147-149
50. Muntz H.G., Goff B.A., Madsen B.L., and Yon J.L. Port-site recurrence after laparoscopic surgery for endometrial carcinoma. Obstet Gynecol 93 (1999) 807-809
51. Wang P.H., Yuan C.C., Lin G., Ng H.T., and Chao H.T. Risk factors contributing to early occurrence of port site metastases of laparoscopic surgery for malignancy. Gynecol Oncol 72 (1999) 38-44
52. Ramirez P.T., Frumovitz M., Wolf J.K., and Levenback C. Laparoscopic port-site metastases in patients with gynecological malignancies. Int J Gynecol Cancer 14 (2004) 1070-1077
53. Sanjuan A., Hernandez S., Pahisa J., et al. Port-site metastasis after laparoscopic surgery for endometrial carcinoma: two case reports. Gynecol Oncol 96 (2005) 539-542
54. Gu M., Shi W., Huang J., Barakat R.R., Thaler H.T., and Saigo P.E. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer 90 (2000) 143-147
55. Grimshaw R.N., Tupper W.C., Fraser R.C., Tompkins M.G., and Jeffrey J.F. Prognostic value of peritoneal cytology in endometrial carcinoma. Gynecol Oncol 36 (1990) 97-100
56. Morrow C.P., Bundy B.N., Kurman R.J., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40 (1991) 55-65
57. Kadar N., Homesley H.D., and Malfetano J.H. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol 46 (1992) 145-149
58. Milosevic M.F., Dembo A.J., and Thomas G.M. The clinical significance of malignant peritoneal cytology in stage I endometrial carcinoma. Int J Gynecol Cancer 2 (1992) 225-235
59. Takeshima N., Nishida H., Tabata T., Hirai Y., and Hasumi K. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol 82 (2001) 470-473
60. Hirai Y., Takeshima N., Kato T., and Hasumi K. Malignant potential of positive peritoneal cytology in endometrial cancer. Obstet Gynecol 97 (2001) 725-728
61. Gucer F., Tamussine K., Moser F., et al. Two-year followup of patients with endometrial carcinoma after preoperative fluid hysteroscpy. Int J Gynecol Cancer 8 (1998) 476-480
62. Swartz M.A., Kristensen C.A., Melder R.J., et al. Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorgenicity. Br J Cancer 81 (1999) 756-759
63. Chambers A.F., Naumov G.N., Vantyghen S.A., et al. Breast cancer metastasis: clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res 2 (2000) 400-407
64. Wyckoff J.B., Jones J.G., Condeelis J.S., and Segall J.E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res. 60 (2000) 2504-2511
65. Vilos A.G., Ettler H.C., Edris F., Hollett-Caines J., and Abu-Rafea B. Endometrioid adenocarcinoma treated by hysteroscopic endomyometrial resection: a case report. J Minim Invasive Gynecol 14 (2007) 205-210